Case Reports in Dermatology (Dec 2021)

Newly Developed Psoriasis in a Patient with Telangiectasia Macularis Eruptiva Perstans and Systemic Mastocytosis Treated with Interferon

  • Tatiana Péčová,
  • Tatiana Burjanivová,
  • Bibiana Malicherová,
  • Martin Jozef Péč,
  • Igor Rohoň,
  • Matúš Madleňák,
  • Katarína Adamicová,
  • Juraj Péč

DOI
https://doi.org/10.1159/000520533
Journal volume & issue
Vol. 13, no. 3
pp. 558 – 562

Abstract

Read online

The authors present a rare case of a patient with telangiectasia macular eruptiva perstans, with confirmed D816V mutation which later progressed to systemic mastocytosis confirmed by trepanobiopsy. First-line treatment – phototherapy – had to be stopped, and systemic treatment with interferon alpha-2a was initiated. The treatment was successful with regression of skin lesions as well as mast cell infiltrates in the bone marrow. However, the treatment was complicated by the onset of psoriasis lesions.

Keywords